188 related articles for article (PubMed ID: 24379688)
1. Once-daily topical treatment for psoriasis: calcipotriene + betamethasone two-compound topical formulation.
Shepherd J; Taheri A; Feldman SR
Clin Cosmet Investig Dermatol; 2013 Dec; 7():19-22. PubMed ID: 24379688
[TBL] [Abstract][Full Text] [Related]
2. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
McCormack PL
Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117
[TBL] [Abstract][Full Text] [Related]
3. A Comparative Study to Evaluate Epidermal Barrier Integrity of Psoriasis Patients Treated With Calcipotriene/Betamethasone Topical Suspension Versus Betamethasone Dipropionate 0.05% Lotion.
Hashim PW; Nia JK; Terrano D; Goldenberg G; Kircik LH
J Drugs Dermatol; 2017 Aug; 16(8):747-752. PubMed ID: 28809989
[TBL] [Abstract][Full Text] [Related]
4. Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.
Menter A; Gold LS; Bukhalo M; Grekin S; Kempers S; Boyce BM; Ganslandt C; Villumsen J; Lebwohl M
J Drugs Dermatol; 2013 Jan; 12(1):92-8. PubMed ID: 23377334
[TBL] [Abstract][Full Text] [Related]
5. Topical long-term therapy of psoriasis with vitamin D₃ analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice.
Augustin M; Mrowietz U; Bonnekoh B; Rosenbach T; Thaçi D; Reusch M; Ardabili M; Reich K
J Dtsch Dermatol Ges; 2014 Aug; 12(8):667-82. PubMed ID: 25039309
[TBL] [Abstract][Full Text] [Related]
6. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial.
Guenther L; Van de Kerkhof PC; Snellman E; Kragballe K; Chu AC; Tegner E; Garcia-Diez A; Springborg J
Br J Dermatol; 2002 Aug; 147(2):316-23. PubMed ID: 12174105
[TBL] [Abstract][Full Text] [Related]
8. A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.
Guenther LC; Poulin YP; Pariser DM
Clin Ther; 2000 Oct; 22(10):1225-38. PubMed ID: 11110233
[TBL] [Abstract][Full Text] [Related]
9. Calcipotriene/betamethasone dipropionate for the treatment of psoriasis vulgaris: an evidence-based review.
Patel NU; Felix K; Reimer D; Feldman SR
Clin Cosmet Investig Dermatol; 2017; 10():385-391. PubMed ID: 29033598
[TBL] [Abstract][Full Text] [Related]
10. Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol.
Cassano N; Miracapillo A; Coviello C; Loconsole F; Bellino M; Vena GA
Clin Drug Investig; 2006; 26(4):227-33. PubMed ID: 17163256
[TBL] [Abstract][Full Text] [Related]
11. Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial.
White S; Vender R; Thaçi D; Haverkamp C; Naeyaert JM; Foster R; Martinez Escribano JA; Cambazard F; Bibby A
Am J Clin Dermatol; 2006; 7(3):177-84. PubMed ID: 16734505
[TBL] [Abstract][Full Text] [Related]
12. Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis.
Kin KC; Hill D; Feldman SR
Expert Rev Clin Pharmacol; 2016 Jun; 9(6):789-97. PubMed ID: 27089906
[TBL] [Abstract][Full Text] [Related]
13. Topical therapy for psoriasis with the use of augmented betamethasone and calcipotriene on alternate weeks.
Singh S; Reddy DC; Pandey SS
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):61-5. PubMed ID: 10863225
[TBL] [Abstract][Full Text] [Related]
14. Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis.
Papp KA; Guenther L; Boyden B; Larsen FG; Harvima RJ; Guilhou JJ; Kaufmann R; Rogers S; van de Kerkhof PC; Hanssen LI; Tegner E; Burg G; Talbot D; Chu A
J Am Acad Dermatol; 2003 Jan; 48(1):48-54. PubMed ID: 12522370
[TBL] [Abstract][Full Text] [Related]
15. Calcipotriene/betamethasone dipropionate foam: primary evidence supporting its use in patients with psoriasis vulgaris. A narrative review.
Narbutt J; Czajkowski R; Lesiak A; Owczarek W; Reich A; Szepietowski JC
Postepy Dermatol Alergol; 2021 Oct; 38(5):727-733. PubMed ID: 34849116
[TBL] [Abstract][Full Text] [Related]
16. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
17. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.
McCormack PL
Drugs; 2011 Apr; 71(6):709-30. PubMed ID: 21504248
[TBL] [Abstract][Full Text] [Related]
18. Calcipotriene 0.005%--betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference.
Sandoval LF; Huang KE; Harrison J; Clark A; Feldman SR
Cutis; 2014 Dec; 94(6):304-9. PubMed ID: 25566573
[TBL] [Abstract][Full Text] [Related]
19. Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris.
van de Kerkhof P; de Peuter R; Ryttov J; Jansen JP
Curr Med Res Opin; 2011 Jan; 27(1):225-38. PubMed ID: 21142833
[TBL] [Abstract][Full Text] [Related]
20. Adolescent Scalp Psoriasis: Update on Topical Combination Therapy.
Osier E; Gomez B; Eichenfield LF
J Clin Aesthet Dermatol; 2015 Jul; 8(7):43-7. PubMed ID: 26203320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
